Personalised Medicine of Cancer

Personalised Medicine of Cancer (PMC) is a biotechnology company focused on advancing precision oncology through comprehensive molecular profiling and diagnostic services. The company provides clinicians with actionable genomic data to guide targeted therapy selection and monitor treatment response in cancer patients. By leveraging next-generation sequencing (NGS) and liquid biopsy technologies, PMC aims to improve patient outcomes by matching individuals with the most effective therapeutic interventions based on their unique genetic profile. Their services encompass a wide range of solid tumors and hematologic malignancies, supporting the shift toward individualized cancer care.